Small interfering RNA targeting N-cadherin regulates cell proliferation and migration in enzalutamide-resistant prostate cancer

Enzalutamide is one of the options for treating patients with castration-resistant or metastatic prostate cancer. However, a substantial proportion of patients become resistant to enzalutamide after a period of treatment. Cells in these tumors typically exhibit increased proliferative and migratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Cheng-Hsin, Wu, Chun-Hsien, Hsieh, Pei-Fang, Wu, Chen-Yu, Kuo, Wade Wei-Ting, Ou, Chien-Hui, Lin, Victor Chia Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805176/
https://www.ncbi.nlm.nih.gov/pubmed/35126732
http://dx.doi.org/10.3892/ol.2022.13210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805176/
https://www.ncbi.nlm.nih.gov/pubmed/35126732
http://dx.doi.org/10.3892/ol.2022.13210

Ejemplares similares